Vistagen Therapeutics Inc (VTGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 39 | 358 | 358 | 354 | 442 |
| Gross Profit | 39 | 358 | 358 | 354 | 442 |
| Operating Expenses | 16,732 | 10,898 | 13,158 | 8,100 | 6,661 |
| Operating Income | -16,693 | -10,540 | -12,800 | -7,746 | -6,219 |
| Other Income | 5 | 5 | 5 | 5 | 8 |
| Pre-tax Income | -16,688 | -10,535 | -12,794 | -7,741 | -6,211 |
| Income Tax | -7 | N/A | N/A | 3 | 0 |
| Net Income Continuous | -16,682 | -10,535 | -12,794 | -7,745 | -6,211 |
| Net Income | $-16,688 | $-10,535 | $-12,794 | $-7,745 | $-6,211 |
| EPS Basic Total Ops | -2.58 | -1.50 | -2.10 | -1.20 | -9.01 |
| EPS Basic Continuous Ops | -2.46 | -1.56 | -1.99 | -1.22 | -0.98 |
| EPS Diluted Total Ops | -2.58 | -1.50 | -2.10 | -1.20 | -9.01 |
| EPS Diluted Continuous Ops | -2.46 | -1.56 | -1.99 | -1.22 | -0.98 |
| EBITDA(a) | $-16,654 | $-10,497 | $-12,763 | $-7,712 | $-6,179 |